she was diagnosed with Covid on Sunday / she was congested.; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (she was diagnosed with Covid on Sunday / she was congested.) in a 69-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 055F22B) for COVID-19 prophylaxis.     Concurrent medical conditions included Hypertension (She had this condition for about 10 years.) and Cholesterol high (she had this condition for about 10 years.). Concomitant products included AMLODIPINE, HCTZ and LISINOPRIL for Blood pressure high, ATORVASTATIN from an unknown date to 22-Jan-2023.    On 28-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 22-Jan-2023, the patient experienced COVID-19 (she was diagnosed with Covid on Sunday / she was congested.). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) on 23-Jan-2023 for COVID-19, at an unspecified dose and frequency. At the time of the report, COVID-19 (she was diagnosed with Covid on Sunday / she was congested.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2023, SARS-CoV-2 test: Positive. On an unknown date, Blood pressure measurement: elevated. On an unknown date, Weight: lost a little weight.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.  The patient was calling to compliment Pfizer on the outstanding packaging used in the Paxlovid. She was diagnosed with Covid on 22 Jan 2023. It was the best packaging of any medication she ever experienced. The description typed out by the pharmacy was confusing. She was able to go straight to the package, it's so clearly labeled on the package. The medications were in packages and color coded with symbols for night and day. It was just the best packaging. No trouble getting into the package, no bottles to have to open. her voice was a bit raspy because she was congested. She thought she had dodged this bullet, her and her husband were both fully vaccinated and boosted, this last round of variants got them.Her doctor had her wait a day, so the Atorvastatin get out of her system since there was a possible interference. She took her Atorvastatin was 22 Jan 2023. She tested positive for Covid 19 on 22 Jan 2023. States that she had previously had the Moderna Covid Vaccines. she took three tablets in the morning, one of the tablets was Nirmatrelvir 150mg the others were Ritonavir 100mg. She took these in the morning, then does the same again in the evening. on 13 Feb 2021, First Dose of the Moderna Covid Vaccine with Lot Number: O11M20A. on 13 Mar 2021, Second Dose of the Moderna Covid Vaccine with Lot Number: 048A21A. on 08 Oct 2021, Booster Dose of the Moderna Covid Vaccine with Lot Number: Unknown. Booster Dose of the Moderna Covid Vaccine Received on 12 Apr 2022; Lot Number: 065K21A. Booster Dose of the Moderna Covid Vaccine: Received on 28 Sep 2022; the bivalent booster; Lot Number: 055F22B.  she has been taking Atorvastatin for 8-10 years. She took her last dose of it on 22 Jan 2023 and then waited until 23 Jan 2023 to start Paxlovid as directed by her doctor. She keeps checking her blood pressure because her doctor warned her that blood pressure may drop down and might have to cut back on her Amlodipine. Her blood pressure had just been elevated some before Covid, she has been checking her blood pressure twice a day and has not needed to cut back on her medication. All her medical conditions started shortly after she went through menopause, states that she was glad it happened though, she likes not having a period anymore.  Description of complaint was Covid 19 after Covid Vaccines Product strength and count size dispensed: 5 Moderna Covid Vaccines. Additional lot numbers: 048A21A; 065K21A; 055F22B  Most recent FOLLOW-UP information incorporated above includes: On 26-Jan-2023: Non significant live follow up (Quality complaint number added)